[Thrombosis and new antithrombotic agents]

Rev Med Interne. 2011 Dec:32 Suppl 2:S236-40. doi: 10.1016/j.revmed.2011.09.011. Epub 2011 Oct 29.

[Article in French]

Authors

L Drouet¹, I Mahé, G Le Gal, M Righini, I Quéré

Affiliation

¹ Angio-hématologie et clinique d'anticoagulation (CREATIF), hôpital Lariboisière, 2, rue Ambroise-Paré, 75010 Paris, France.

PMID: 22041519
DOI: 10.1016/j.revmed.2011.09.011

No abstract available

Publication types

Review

MeSH terms

Atrial Fibrillation / drug therapy
Choice Behavior / physiology
Drug Administration Schedule
Drug Substitution / methods
Drugs, Investigational / administration & dosage
Drugs, Investigational / adverse effects
Drugs, Investigational / pharmacology
Drugs, Investigational / therapeutic use*
Fibrinolytic Agents / administration & dosage
Fibrinolytic Agents / adverse effects
Fibrinolytic Agents / pharmacology
Fibrinolytic Agents / therapeutic use*
Hemorrhage / chemically induced
Hemorrhage / prevention & control
Humans
Product Surveillance, Postmarketing
Thrombosis / drug therapy*

Substances

Drugs, Investigational
Fibrinolytic Agents